Delivery Order SPE2DB20D1100-SPE2DB25FB7Z8
Award Date
4/17/25
Potential Completion Date
4/18/25
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $9,256.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract to supply 4567943059 VRAYLAR 1.5 MG CAPSULE 30S, with a completion date of April 17, 2025. The contract is a firm-fixed-price arrangement, and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,625.35 firm fixed-price delivery order is to provide VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,494.63, is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a specialty medication. This is a firm fixed-price delivery order contract with an ultimate completion date of April 11, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,747.02 firm fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, with a period of performance ending on May 16, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a...
This federal contract award, valued at $8,154.96, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corporation. The contract is for the delivery of 4566358010 - VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 7, 2024. Amerisourcebergen Drug Corporation is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award is a delivery order valued at $7,311.53 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, with a performance period through May 22, 2025. Amerisourcebergen Drug Corp is the prime contractor on this non-set-aside contract. This award is associated with Amerisourcebergen's broader Indefinite Delivery Contract...
This federal contract award, valued at $7,725.78, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a Delivery Order contract type with a Firm Fixed Price pricing structure. The contract covers the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a completion date of September 22, 2023. The contract was not set aside for any specific business type....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,147.30 firm-fixed-price delivery order is for the supply of 4568249621 - VRAYLAR 1.5 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of May 15, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,419.98 firm-fixed-price delivery order is for the supply of 4568189134 - VRAYLAR 1.5 MG CAPSULE UD 20S, a prescription medication. The contract has an ultimate completion date of May 9, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $10,550.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, identified as Delivery Order SPE2DB20D1100|SPE2DB24FA3F9, is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of February 21, 2024. AmerisourceBergen holds a significant Indefinite...